Options to expand HIV viral load testing in South Africa: Evaluation of the genexpert® HIV-1 viral load assay

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Gous, Natasha ^a,b   Scott, Lesley ^a   Berrie, Leigh ^b   Stevens, Wendy ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRIED BLOOD SPOT TESTING; FEMALE; HIV TEST; HUMAN; INTRARATER RELIABILITY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PREDICTIVE VALUE; RAPID TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VIRUS LOAD; BLOOD; EVALUATION STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; SPECIMEN HANDLING;

VIRUS RNA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPECIMEN HANDLING; VIRAL LOAD;

EID: 85006815312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168244     Document Type: Article

References (24)

1. World Health Organisation. Supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection recommendations for a public health approach. March 2014. Available from: http://www.zero-hiv.org/wp-content/uploads/2014/03/Technical-Report- template-Topic5-27feb-FINAL-LR-WEB.pdf
2. Ferreyra C, Yun O, Eisenberg N, Alonso E, Khamadi AS, Mwau M, et al. Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya. PLoS One. 2012; 7(11):e49834. doi: 10.1371/journal.pone.0049834 PMID: 23185450
3. Glencross DK, Coetzee LM, Cassim N. An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme. PLoS One. 2014; 9(12):e114727. doi: 10. 1371/journal.pone.0114727 PMID: 25490718
4. UNAIDS. 90-90-90: An Ambitious treatment target to help end the AIDS epidemic. 8 October 2014. Available from: http://www.unaids.org/en/resources/documents/2014/90-90-90.
5. Cepheid. Media release: World's Most Portable Molecular Diagnostics System Unveiled at AACC GeneXpert Omni to Further Decentralize Critical TB, Virology and Ebola Tests. July 2015. Available from: http://ir.cepheid.com/releasedetail.cfm?releaseid=924108
6. PRnewsWire. Cepheid and FIND Announce European Approval of Xpert HIV-1 Viral Load. 29 December 2014. Available from: http://www.prnewswire.com/news-releases/cepheid-and-find-announceeuropean-approval-of-xpert-hiv-1-viral-load-300014112.html.
7. Cepheid. HIV-1 Quant manual, Rev 1.1. Sweden: Cepheid AB; June 2014
8. Ceffa S, Luhanga R, Andreotti M, Brambilla D, Erba F, Jere H, et al. Comparison of the Cepheid GeneXpert and Abbott M2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infection. J Virol Methods. 2015; 229:35-9. doi: 10.1016/j.jviromet.2015.12.007 PMID: 26709099
9. Gueudin M, Baron A, Alessandri-Gradt E, Lemée V, Mourez T, Plantier J. Presentation at ESCV 2015: Poster 2 Evaluation of the Xpert HIV-1 viral load assay on a wide panel of HIV-1 variants. Abstracts / Journal of Clinical Virology. 2015; 70(S1-S126).
10. Mor O, Gozlan Y, Wax M, Mileguir F, Rakovsky A, Noy B, et al. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load. J Clin Microbiol. 2015; 53(11):3458-65 doi: 10.1128/JCM.01806-15 PMID: 26292298
11. Scott LE, Carmona S, Gous N, Horsfield P, Mackay M, Stevens W. Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing. J Clin Microbiol. 2012; 50(12):4083-6. doi: 10. 1128/JCM.01355-12 PMID: 22993182
12. Cvitkovic M. Point-of-care testing. Conception, regulations, and usage. Crit Care Nurs Q. 2011; 34 (2):116-27. doi: 10.1097/CNQ.0b013e31820f6f0a PMID: 21407006
13. Lin LI-K. A note on the concordance correlation coefficient. Biometrics. 2000; 56:324-5.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. PMID: 2868172
15. McBride GB. A proposal for strength of agreement criteria for Lins Concordance Correlation Coefficient. NIWA client report HAM2005-062 Report for Ministry of Health. 2005.
16. Bilic-Zulle L. Comparison of methods: Passing and Bablok regression. Biochem Med (Zagreb). 2011; 21(1):49-52.
17. Scott LE, Galpin JS, Glencross DK. Multiple method comparison: statistical model using percentage similarity. Cytometry B Clin Cytom. 2003; 54(1):46-53. doi: 10.1002/cyto.b.10016 PMID: 12827667
18. MedCalc. Online Medical calculators. Available from: www.medcalc.com.
19. Gous N, Cunningham B, Kana B, Stevens W, Scott LE. Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol. 2013; 51(12):4018-21. doi: 10.1128/JCM.01715-13 PMID: 24068004
20. Scott LE, Gous N, Cunningham BE, Kana BD, Perovic O, Erasmus L, et al. Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol. 2011; 49(12):4356-60. doi: 10.1128/JCM.05167-11 PMID: 21976767
21. World Health Organisation. Technical and operational considerations for implementing HIV viral load testing. July 2014. Available: http://www.who.int/hiv/pub/arv/viral-load-testing-technical-update/en/ [Accessed 10.03.2016].
22. Scott LE, Noble LD, Moloi J, Erasmus L, Venter WD, Stevens W. Evaluation of the Abbott m2000 Real-Time human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. J Clin Microbiol. 2009; 47(7):2209-17. doi: 10. 1128/JCM.01761-08 PMID: 19420172
23. Roche. Cobas® 6800/8800 Systems, Explore the future of molecular testing. April 2015. Available from: https://www.cobas68008800.com/.
24. Cepheid. Remote Connectivity. In 5th Annual GLI Partners' Meeting, Les Pensières, Veyrie-du-Lac, France, 15-18 April 2013.